ASO Visual Abstract: Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair-Modelling Oncological Outcomes and Numbers Needed to Treat

Arezo Kanani; Torhild Veen; Dordi Lea; Claudia Zaharia; Martin Watson; Marina Alexeeva; Kenneth Thorsen; Kjetil Søreide

doi:10.1245/s10434-025-16899-5

ASO Visual Abstract: Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair-Modelling Oncological Outcomes and Numbers Needed to Treat

Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-025-16899-5. Online ahead of print.

Authors

Arezo Kanani^{1

2}, Torhild Veen^{1

2}, Dordi Lea^{2

3}, Claudia Zaharia^{2

3}, Martin Watson^{1

2}, Marina Alexeeva^{1

2}, Kenneth Thorsen^{1

4}, Kjetil Søreide^{5

6

7}

Affiliations

¹ Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway.
² Gastrointestinal Translational Research Unit, Molecular Laboratory, Stavanger University Hospital, Stavanger, Norway.
³ Department of Pathology, Stavanger University Hospital, Stavanger, Norway.
⁴ Department of Clinical Medicine, University of Bergen, Bergen, Norway.
⁵ Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway. ksoreide@mac.com.
⁶ Gastrointestinal Translational Research Unit, Molecular Laboratory, Stavanger University Hospital, Stavanger, Norway. ksoreide@mac.com.
⁷ Department of Clinical Medicine, University of Bergen, Bergen, Norway. ksoreide@mac.com.

PMID: 39849254
DOI: 10.1245/s10434-025-16899-5

No abstract available